{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2018-0003","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2018-0003","name":[{"text":"Zoster: Dose #2 (Shingrix) administered at 4 weeks after dose #1\nEvaluation_Test_Type: All Valid: Forecast Test\nGeneral_Description: This test case describes when a patient is administered dose #2 of the RZV vaccine 4 weeks after the first dose that the series is considered complete."}],"gender":"female","birthDate":"1970-06-01"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2018-0003-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"187","display":"zoster recombinant"}]},"patient":{"reference":"Patient/2018-0003"},"date":"2020-06-01T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2018-0003-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"187","display":"zoster recombinant"}]},"patient":{"reference":"Patient/2018-0003"},"date":"2020-06-29T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}}]}